Radiculopathy Global Clinical Trials Review, H1, 2018: Ken Research

0


Radiculopathy is commonly known as pinched nerve. It is a condition where one or more nerves are affected and stop performing its functions. This condition leads to pain, weakness, numbness and difficulty in controlling certain muscles. The pain generally occurs at the root of the nerve in radiculopathy. It also affects that part of the body that the nerve serves. The causes of radiculopathy maybe secondary to degenerative disc disease, osteoarthritis, facet joint degeneration, or a combination of such factors. Some rare causes include diabetes mellitus, neoplastic disease, radiation and so on.

Clinical trials are conducted in medical research labs to find better ways to prevent and treat diseases or diagnose them. They give solutions on the medical approaches suitable for certain illness to a certain group of people specifically. These trials help a great deal in making healthcare decisions. Since they answer scientific questions, these trials are required to be carried on under strict and scientific standards that protect the interests of the patients. They are also the final and the most important stage of clinical research and development. Clinical trials for drugs take place in four phases- first, they test an experimental drug on a few people and study the effects; second, they test the drug on more people than in Phase 1 which may extend up to years; third, they include many other participants to test for safety and efficacy and study the side effects deeper than in Phase 2; fourth, getting approval of the usage of drug from the relevant authority.

Ken Research’s Radiculopathy Global Clinical Trials Review, H1, 2018 gives an overview of the global clinical trials landscape and top-level data related to clinical trials by Regio, Country (G7 and E7), Trial Status, trial Phase, Sponsor type and End point status. The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company and all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for their non-accomplishments. It provides enrolment trends for the past five years and the latest news relating to these trials for the past three months. The companies involved in the clinical trials of Radiculopathy are Biogen Inc, Semnur Pharmaceuticals Inc, Pfizer Inc, Pacira Pharmaceuticals Inc, CMAX, Celgene Corp, BioAssets Development Corp, Aurous HealthCare Research and Development India Pvt Ltd, Astellas Pharma Inc and Allodynic Therapeutics LLC. The report will enhance the decision- making capabilities and helps to create an effective counter strategy to gain competitive advantage.

For more information, click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/radiculopathy-global-clinical/154896-91.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91 9015378249

Share.

Comments are closed.